Learn The Law and Represent Yourself in Court
Share
-
Plaintiff Awarded More Than $500m In Propofol Hepatitis C Lawsuit
Jurors in a Las Vegas courtroom held Teva and Baxter pharmaceuticals responsible for Henry Chanin, 62, having contracted Hepatitis C from contaminated propofol, an anesthetic that both companies distribute.
Chanin sued Teva Parenteral Medicines Inc. and Baxter Healthcare Corp. after contracting Hepatitis when he was administered propofol at the Desert Shadow Endoscopy Center. Tens of thousands of patients were placed at risk because of failure to comply with procedures recommended for anesthesia professionals handling propofol. The jury found however that the two companies created the danger because of their methods of packaging propofol in large vials.
Because of its unique protein composition, propofol is an ideal auger for growing various bacteria and viruses and should not be used on multiple patients, despite large 50-100 ml vials marketed similar to multi-dose vials of other medications.
Chanin is one of hundreds who have filed suit.The jury awarded Chanin $3.25 million in compensatory damages. His wife, Lorraine, was awarded $1.85 million for loss of consortium. Punitive damages were also awarded and the jury was deliberating today to determine the amount.
Read more:
Related Posts
- Nevada Hepatitis C Outbreak Lawsuit Update [VIDEO]
- Second Hepatitis C Trial Underway Against Propofol Maker
- Nevada Supreme Court Issues important Evidence Rulings In Hepatitis C Cases
- Teva Appeals $500M Verdict In Nevada Hep C Case: Serious Issues
- Attorney Seeks $1 Billion In Punitive Damages In Hep C Propofol Trial
[...] Plaintiff Awarded More Than $5m In Propofol Hep C Lawsuit | Law … [...]
[...] Plaintiff Awarded More Than $5m In Propofol Hep C Lawsuit | Law Med Blog [...]
[...] has been over a year since we told you about a jury verdict in Nevada against Teva Pharmaceuticals a while ago that cost them $500 Million Dollars. The case [...]
[...] the first similar case tried the jury awarded the plaintiff $500 million in punitive damages, an award later reversed by the US Supreme Court which found that generic drug [...]